Diet, physical exercise and Orlistat administration increase serum Anti-Mullerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

被引:32
|
作者
Vosnakis, Christos [1 ]
Georgopoulos, Neoklis A. [2 ]
Rousso, David [1 ]
Mavromatidis, Georgios [1 ]
Katsikis, Ilias [3 ]
Roupas, Nikolaos D. [2 ]
Mamali, Irene [2 ]
Panidis, Dimitrios [3 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 3, GR-54006 Thessaloniki, Greece
[2] Univ Patras, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, Patras 26500, Greece
[3] Aristotle Univ Thessaloniki, Dept Obstet & Gynecol 2, Div Endocrinol & Human Reprod, GR-54006 Thessaloniki, Greece
关键词
Anti-Mullerian Hormone; LH; insulin resistance; Orlistat; PCOS; INHIBITING SUBSTANCE LEVELS; LUTEINIZING-HORMONE; INSULIN-RESISTANCE; MOUSE OVARY; LEAN WOMEN; OBESITY; GROWTH; ASSOCIATION; GHRELIN; FSH;
D O I
10.3109/09513590.2012.736557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study investigates the combined effect of diet, physical exercise and Orlistat for 24 weeks, on serum Anti-Mullerian Hormone (AMH) levels in overweight and obese women with polycystic ovary syndrome (PCOS) and in overweight and obese controls. Sixty-one (61) selected women with PCOS and 20 overweight and obese controls followed an energy-restricted diet, physical exercise plus Orlistat administration (120 mg, 3 times per day) for 24 weeks. At baseline, week 12 and week 24, serum levels of AMH, FSH, LH, PRL, androgens, sex hormone-binding globulin (SHBG), glucose, and insulin were measured and Free Androgen Index (FAI) and Insulin Resistance (IR) indices were calculated. In PCOS women, serum AMH levels increased after 12 and 24 weeks of treatment. After 12 weeks LH and SHBG were increased, while Testosterone decreased. After 12 and 24 weeks, FAI was decreased and all indices of IR were significantly improved. We concluded that in overweight and obese women with PCOS Orlistat administration, combined with diet and physical exercise, for 24 weeks, resulted in significant weight loss, improvement of hyperandrogenism and insulin sensitivity, and increased serum AMH levels.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [1] Anti-Mullerian Hormone (AMH) Levels in Women with and without Polycystic Ovary Syndrome (PCOS)
    Sadiq, Iftikhar
    Qamar, Misbahul
    Janjua, Qasim Mehmood
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (02): : 564 - 566
  • [2] Sibutramine administration decreases serum anti-Mullerian hormone (AMH) levels in women with polycystic ovary syndrome
    Vosnakis, Christos
    Georgopoulos, Neoklis A.
    Armeni, Anastasia K.
    Papadakis, Efstathios
    Roupas, Nikolaos D.
    Katsikis, Ilias
    Panidis, Dimitrios
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (02) : 185 - 189
  • [3] SERUM ANTI-MULLERIAN HORMONE LEVELS (AMH) DECREASE AFTER METFORMIN ADMINISTRATION IN WOMEN WITH BOTH LEAN AND OVERWEIGHT POLYCYSTIC OVARY SYNDROME (PCOS)
    Sauerbrun-Cutler, M.
    Lederman, M.
    Keltz, M.
    Lee, M.
    Stein, D.
    FERTILITY AND STERILITY, 2012, 98 (03) : S213 - S213
  • [4] Serum Anti-Mullerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses
    Detti, Laura
    Christiansen, Mary E.
    Francillon, Ludwig
    Ikuwezunma, Gini
    Diamond, Michael P.
    Mari, Giancarlo
    Tobiasz, Ana M.
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2019, 65 (02) : 147 - 154
  • [5] Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
    Falbo, Angela
    Rocca, Morena
    Russo, Tiziana
    D'Ettore, Antonietta
    Tolino, Achille
    Zullo, Fulvio
    Orio, Francesco
    Palomba, Stefano
    JOURNAL OF OVARIAN RESEARCH, 2010, 3
  • [6] Serum and follicular anti-Mullerian hormone levels in women with polycystic ovary syndrome (PCOS) under metformin
    Angela Falbo
    Morena Rocca
    Tiziana Russo
    Antonietta D'Ettore
    Achille Tolino
    Fulvio Zullo
    Francesco Orio
    Stefano Palomba
    Journal of Ovarian Research, 3
  • [7] Is the anti-Mullerian hormone (AMH) involved in the follicular arrest of the polycystic ovary syndrome (PCOS)?
    Jonard, S
    Decanter, C
    Pigny, P
    Dewailly, D
    FERTILITY AND STERILITY, 2005, 84 : S150 - S151
  • [8] The Increased Prevalence of Regular Cycles in Women with Polycystic Ovary Syndrome (PCOS) with Aging Is Associated with Lower Levels of Serum Anti-Mullerian Hormone (AMH).
    Kort, Daniel H.
    Carmina, Enrico
    Campagna, Anna Maria
    Mansueto, Pasquale
    Lobo, Roger A.
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 207A - 207A
  • [9] Hormone profiling, including anti-Mullerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes
    Sova, Henri
    Unkila-Kallio, Leila
    Tiitinen, Aila
    Hippelainen, Maritta
    Perheentupa, Antti
    Tinkanen, Helena
    Puukka, Katri
    Bloigu, Risto
    Piltonen, Terhi
    Tapanainen, Juha S.
    Morin-Papunen, Laure
    GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (07) : 595 - 600
  • [10] The role of serum anti-Mullerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome
    Casadei, Luisa
    Madrigale, Alessandra
    Puca, Francesco
    Manicuti, Claudia
    Emidi, Emanuela
    Piccione, Emilio
    Dewailly, Didier
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (06) : 545 - 550